Clinical trial

Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC

NCT07705438

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-05-28

PhaseN/A

Study timeline

Study start (actual)2025-05-28Date precision: day

Registry last updated2026-07-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Cancerunresolved

Immune Checkpoint Inhibitorunresolved

Granzyme B PET/CTunresolved

Interventions

[68Ga]Ga-DOTA-GSI PET/CT (Granzyme B PET/CT)OTHER

Sponsors & collaborators

Fudan Universitylead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07705438 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.